GlassScriptPhysician profile
Christopher Michael Paprzycki
NPI 1457613838
$39,507.30
in general payments reported to CMS, 2019-2025
30 companies · $13K in 2025
The $13K reported for 2025 was more than what 92% of Vascular Surgery providers received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,790 · 2020: $1,948 · 2021: $797 · 2022: $929 · 2023: $2,835 · 2024: $15K · 2025: $13K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $17K · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $6,600 · Food and Beverage: $5,823 · Travel and Lodging: $1,433.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $17,187.50 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $6,600.00 |
| Food and Beverage | $5,823.09 |
| Travel and Lodging | $1,433.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shockwave Medical, INC | $24,559.21 | 2019-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Abbott Laboratories | $4,960.19 | 2019-2025 | Esprit, Jeti, Xact |
| Penumbra, INC. | $2,515.47 | 2019-2025 | Indigo System, Penumbra System |
| Boston Scientific Corporation | $1,245.37 | 2019-2024 | Ranger |
| Silk Road Medical, INC. | $1,188.63 | 2019-2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Cardiovascular Systems INC. | $1,143.41 | 2019 | |
| W. L. Gore & Associates, INC. | $702.68 | 2019-2023 | Gore Viabahn Vbx Balloon Expandable Endo, Product In Development |
| Bolton Medical INC | $582.89 | 2019-2022 | |
| Angiodynamics, INC. | $579.29 | 2025 | Alphavac, Auryon Laser System 100-120 Vac |
| Bard Peripheral Vascular, INC. | $441.57 | 2019-2024 | Lutonix Drug Coated Balloon, Rotarexs 6 F X 135 Cm, Fluency Endovascular Stent Graft |
| Medtronic, INC. | $384.35 | 2021-2025 | Endurant Iis, Abre |
| Stryker Corporation | $238.79 | 2020-2025 | Flowtriever, Limflow System, Flowtriever Catheter, S |
| Inari Medical, INC. | $220.40 | 2020-2021 | |
| Reflow Medical INC | $186.40 | 2024-2025 | |
| Philips North America LLC | $179.40 | 2021-2025 | IV Other |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intersect Ent, INC. | $76.08 | 2019 | |
| Janssen Pharmaceuticals, INC | $40.07 | 2019 | |
| Surmodics, INC. | $34.33 | 2024-2025 | Pounce Thrombectomy, Pounce Venous Thrombectomy System, Pounce Thrombectomy System |
| Trisalus Life Sciences, INC. | $32.23 | 2025 | Trinav Infusion System |
| Cook Medical LLC | $29.38 | 2019-2022 | |
| Lemaitre Vascular, INC. | $21.98 | 2019 | |
| Ekos Corporation | $20.73 | 2019 | |
| Chiesi USA, INC. | $20.14 | 2020 | |
| Avinger INC. | $19.36 | 2019 | |
| Medistim USA, INC. | $15.00 | 2019 | |
| Portola Pharmaceuticals, LLC | $14.93 | 2019 | |
| Pfizer INC. | $14.78 | 2019 | |
| Getinge USA Sales, LLC | $14.75 | 2020 | |
| Acell, INC. | $13.51 | 2019 | |
| Medtronic Vascular, INC. | $11.98 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Paprzycki listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.